1. FC070: Lumasiran for Patients with Primary Hyperoxaluria Type 1 with Impaired Kidney Function: Data from the 6-Month Analysis of the Phase 3 Illuminate-C Trial. (3rd May 2022) Authors: Groothoff, Jaap; Michael, Mini; Shasha-Lavsky, Hadas; Lieske, John; Frishberg, Yaacov; Simkova, Eva; Sellier-Leclerc, Anne-Laure; Arnaud, Devresse; Guebre-Egziabher, Fitsum; Azime Bakkaloglu, Sevcan; Mourani, Chebl; Saqan, Rola; Singer, Richard; Willey, Richard; Habtemariam, Bahru; Bhan, Ishir; G... Journal: Nephrology dialysis transplantation Issue: Volume 37(2022)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. LB002ILLUMINATE-A, A PHASE 3 STUDY OF LUMASIRAN, AN INVESTIGATIONAL RNAI THERAPEUTIC, IN CHILDREN AND ADULTS WITH PRIMARY HYPEROXALURIA TYPE 1 (PH1). (7th June 2020) Authors: Garrelfs, Sander; Frishberg, Yaacov; Hulton, Sally; Koren, Michael; O'Riordan, William; Cochat, Pierre; Deschenes, Georges; Shasha-Lavsky, Hadas; Saland, Jeffrey; Van't Hoff, William; Fuster, Daniel Guido; Magen, Daniella; Moochhala, Shabbir; Schalk, Gesa; Simkova, Eva; Groothoff, Jaap; Sas, Davi... Journal: Nephrology dialysis transplantation Issue: Volume 35(2020)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PD05-03 EFFICACY AND SAFETY OF LUMASIRAN IN PATIENTS WITH PRIMARY HYPEROXALURIA TYPE 1: 24-MONTH ANALYSIS OF THE ILLUMINATE-A TRIAL. (May 2022) Authors: Lieske, John; Groothoff, Jaap; Frishberg, Yaacov; Sellier-Leclerc, Anne-Laure; Shasha-Lavsky, Hadas; Saland, Jeffrey; Hayes, Wesley; Magen, Daniella; Moochhala, Shabbir; Coenen, Martin; Simkova, Eva; Ngo, Taylor; Gansner, John; Hulton, Sally-Anne Journal: Journal of urology Issue: Volume 207(2022)Supplement 5 Page Start: e87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗